表紙
市場調查報告書

細胞化驗分析的全球市場 至2024年的預測:各產品 (試劑、微孔盤、細胞株、化驗套件、設備、服務)、用途、終端用戶、地區

Cell-based Assay Market by Product (Reagents, Microplates, Cell Lines, Assay Kits, Instruments, Services), Application (Drug Discovery, Research), End User (CROs, Biopharma Companies, Research Institutes), Geography - Global Forecast to 2024

出版商 MarketsandMarkets 商品編碼 301568
出版日期 內容資訊 英文 133 Pages
訂單完成後即時交付
價格
Back to Top
細胞化驗分析的全球市場 至2024年的預測:各產品 (試劑、微孔盤、細胞株、化驗套件、設備、服務)、用途、終端用戶、地區 Cell-based Assay Market by Product (Reagents, Microplates, Cell Lines, Assay Kits, Instruments, Services), Application (Drug Discovery, Research), End User (CROs, Biopharma Companies, Research Institutes), Geography - Global Forecast to 2024
出版日期: 2019年04月01日內容資訊: 英文 133 Pages
簡介

全球細胞化驗分析市場預計2019年達139億美元,2024年達189億美元,並以6.3%的年複合成長率 (CAGR) 成長。研究資金的增加和藥物研發活動的活躍等,為市場成長的主要原因。各用途中基礎研究需求佔最大的佔有率,以及各地區中亞太地區各國今後預計將急速成長。

本報告提供全球細胞化驗分析的市場相關調查,各提供產品/服務、用途、終端用戶、地區的市場趨勢,市場規模與成長率的變化與預測,市場推動成長、阻礙因素以及市場機會分析,競爭環境,主要企業的簡介等系統性資訊。

第1章 簡介

第2章 分析方法

第3章 摘要整理

第4章 重要考察

第5章 市場概要

  • 簡介
  • 市場動態
    • 促進因素
      • 對細胞化驗分析的偏好擴大
      • 研究資金的增額
      • 藥物研發活動的增加
    • 阻礙因素
      • 檢驗設備的成本高,並以對試劑利用的限制
    • 市場機會
      • 亞洲各國的急速成長
      • 癌症研究的最新型的細胞化驗分析的有效利用

第6章 細胞化驗分析市場:各產品、服務

  • 簡介
  • 消耗品
    • 試劑
    • 化驗套件
      • 報導基因分析
      • 次級訊號化驗
      • 細胞生長化驗
      • 細胞死亡化驗
      • 其他
    • 探針、標籤
    • 微孔盤
    • 細胞株
      • 永生細胞股
      • 第一代細胞株
      • 幹細胞株
    • 其他
  • 設備
  • 服務

第7章 細胞化驗分析市場:各用途

  • 簡介
  • 藥物研發
    • 毒性研究
    • 藥物動力學研究
    • 藥效學的研究
  • 基礎研究
  • 其他

第8章 細胞化驗分析市場:各終端用戶

  • 簡介
  • 製藥企業、生物科技企業
  • 教育機關、政府機關
  • CRO (醫藥品臨床研究委外機構)

第9章 細胞化驗分析市場:各地區

  • 簡介
  • 北美 (美國,加拿大)
  • 歐洲 (英國,德國,法國等)
  • 亞太地區 (中國,日本,印度等)
  • 其他的國家 (RoW)

第10章 競爭環境

  • 概要
  • 市場排行榜分析
    • 細胞化驗分析的市場排行榜:主要企業的情況
  • 主要策略 (過去4年份)
    • 產品銷售
    • 事業擴張
    • 事業合作
    • 企業收購
  • 企業策略方向性:製圖
    • 先驅企業
    • 創新企業
    • 活動企業
    • 新企業
  • 企業策略方向性:Start-Ups企業的情況
    • 進步企業
    • 新加入企業
    • 模仿的企業
    • 活動的企業

第11章 企業簡介

  • THERMO FISHER SCIENTIFIC INC.
  • DANAHER CORPORATION
  • BECTON, DICKINSON AND COMPANY
  • GE HEALTHCARE
  • MERCK KGAA
  • LONZA GROUP LTD.
  • PERKINELMER, INC.
  • CHARLES RIVER LABORATORIES, INC.
  • CELL SIGNALING TECHNOLOGY, INC.
  • PROMEGA CORPORATION
  • CISBIO
  • CELL BIOLABS, INC.

第12章 附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: BT 2486

"Cell-based assays market to register a CAGR of 6.3% from 2019 to 2024"

The cell-based assays market is projected to reach USD 18.9 billion by 2024 from USD 13.9 billion in 2019, at a CAGR of 6.3% during the forecast period. Growth in this market is mainly driven by the increasing research funding, and the growth in the number of drug discovery activities. Emerging economies with growing R&D expenditures are also expected to provide opportunities for the growth of the market.

"Services exhibited the highest CAGR over the forecast period."

By product & service, the cell-based assays market is segmented into consumables, instruments and services. Over the forecast period, the services segment accounted for the highest CAGR. The increased R&D investments and technological innovations in supportive processes such as high-throughput screening is driving the growth of this product & service segment.

"Basic research held the significant share in the cell-based assays market in 2019"

On the basis of application, the cell-based assays market is segmented into drug discovery, basic research and other research such as quality check among others. In 2019, the drug discovery segment accounted for the largest share of the cell-based assays market. The large share of this segment can be attributed to the rising adoption of in vitro testing over animal testing and increasing in R&D spending by biopharmaceutical companies.

"Asia Pacific exhibited the highest CAGR over the forecast period"

North America, which includes the US and Canada, accounted for the largest share of the cell-based assays market. The large share of this market segment can be attributed to the increasing drug discovery activities by pharmaceutical and biotechnology companies. In addition to this, consolidations between academic and government institutes with biopharmaceutical companies in the region are also driving the growth of this market.

Breakdown of supply-side primary interviews, by company type, designation, and region:

  • By Company Type: Tier 1 (20%), Tier 2 (45%), and Tier 3 (35%)
  • By Designation: C-level (30%), Director-level (20%), and Others (50%)
  • By Region: North America (35%), Europe (24%), Asia Pacific (25%), and RoW (16%)

Some of the major players in this market include: Thermo Fisher Scientific, Inc. (US), Danaher Corporation (Beckman Coulter, Inc.) (US), Becton, Dickinson and Company (US), GE Healthcare (US), Merck KGaA (Germany), Lonza Group (Switzerland), PerkinElmer, Inc. (US), Charles River Laboratories, Inc. (US), Cell Signaling Technologies (US), Cisbio (US), Cell Biolabs, Inc. (US), and Promega Corporation (US).

Research Coverage:

This report studies the cell-based assays market based on products, applications, end users, and regions. The report also analyzes factors (such as drivers, opportunities, and challenges) affecting market growth. It evaluates opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total cell-based assays market. The report forecasts the revenue of the market segments with respect to four major regions.

Reasons to Buy the Report:

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the cell-based assays offered by the top 10 players in the cell-based assays market. The report analyzes the cell-based assays market by product, , end user, application, and region
  • Market Development: Comprehensive information about the lucrative emerging markets. The report analyzes the markets for various cell-based assays across key geographic regions
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the cell-based assays market
  • Competitive Assessment: In-depth assessment of market shares and strategies of the leading players in the cell-based assays market

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
    • 1.2.1 MARKETS COVERED
    • 1.2.2 YEARS CONSIDERED FOR THE STUDY
  • 1.3 CURRENCY
  • 1.4 LIMITATIONS
  • 1.5 STAKEHOLDERS

2 RESEARCH METHODOLOGY

    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Key Data from Secondary Sources
    • 2.1.2 PRIMARY DATA
      • 2.1.2.1 Key data from primary sources
  • 2.2 MARKET SIZE ESTIMATION
    • 2.2.1 BOTTOM-UP APPROACH
    • 2.2.2 TOP-DOWN APPROACH
  • 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.4 ASSUMPTIONS FOR THE STUDY

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 CELL-BASED ASSAYS: MARKET OVERVIEW
  • 4.2 CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE AND APPLICATION (2018)
  • 4.3 GEOGRAPHICAL SNAPSHOT OF THE CELL-BASED ASSAYS MARKET

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Growing preference for cell-based assays
      • 5.2.1.2 Growing research funding
      • 5.2.1.3 Growth in the number of drug discovery activities
    • 5.2.2 RESTRAINT
      • 5.2.2.1 High cost of instruments and restrictions on reagent use
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 High-growth Asian countries
      • 5.2.3.2 Application of novel cell-based assays in cancer research

6 CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE

  • 6.1 INTRODUCTION
  • 6.2 CONSUMABLES
    • 6.2.1 REAGENTS
      • 6.2.1.1 Reagents have widespread usage in life sciences due to their application in immunology research, disease research, and cancer diagnostics
    • 6.2.2 ASSAY KITS
      • 6.2.2.1 Reporter gene assays
        • 6.2.2.1.1 Reporter gene assays can be used with limited resources for the establishment of HTS platforms, presenting opportunities for small laboratories with limited resources
      • 6.2.2.2 Second messenger assays
        • 6.2.2.2.1 Second messenger assays allow the detection and characterization of all compound classes-a key driver for market growth
      • 6.2.2.3 Cell growth assays
        • 6.2.2.3.1 Cell viability and cell proliferation assays are the two most important in vitro quantification techniques for assessing cell growth
      • 6.2.2.4 Cell death assays
        • 6.2.2.4.1 Cell death quantification is essential in drug development to identify the manner in which potential drugs could inhibit or enhance molecular targets-a key factor propelling market demand
      • 6.2.2.5 Other assay kits
    • 6.2.3 PROBES & LABELS
      • 6.2.3.1 Effective labeling of cells helps in studying cellular events in a spatial and temporal context-a key factor driving the demand for probes and labels
    • 6.2.4 MICROPLATES
      • 6.2.4.1 Increasing demand for cell-based assays in drug discovery, basic research, and preclinical safety studies is encouraging the consumption of microplates
    • 6.2.5 CELL LINES
      • 6.2.5.1 Immortalized cell lines
        • 6.2.5.1.1 Advantages of immortalized cell lines creating a demand for these cell lines over primary and stem cell lines
      • 6.2.5.2 Primary cell lines
        • 6.2.5.2.1 Primary cell lines are more sensitive as compared to immortalized cell lines-a key factor limiting market growth
      • 6.2.5.3 Stem cell lines
        • 6.2.5.3.1 Stem cell lines are alternative methodologies to address the cellularity issues that involve the directed differentiation of embryonic stem (ES) cells or induced pluripotent stem cells (iPS)
    • 6.2.6 OTHER CONSUMABLES
  • 6.3 INSTRUMENTS
    • 6.3.1 BIOTECHNOLOGY COMPANIES AIM TO STREAMLINE THEIR WORKFLOWS TO IMPROVE PRODUCTIVITY AND REDUCE COSTS, WHICH WILL DRIVE THE GROWTH OF THE INSTRUMENTS MARKET
  • 6.4 SERVICES

7 CELL-BASED ASSAYS MARKET, BY APPLICATION

  • 7.1 INTRODUCTION
  • 7.2 DRUG DISCOVERY
    • 7.2.1 TOXICITY STUDIES
      • 7.2.1.1 Increasing adoption of high-content screening for evaluating cytotoxicity is a factor stimulating the use of cell-based assays for toxicity studies
    • 7.2.2 PHARMACOKINETIC STUDIES
      • 7.2.2.1 Demand for ADME studies to rise due to the growing need for improved clinical success-a major factor driving growth
    • 7.2.3 PHARMACODYNAMIC STUDIES
      • 7.2.3.1 Increasing number of pharmacodynamics studies globally to drive growth in the cell-based assays market
  • 7.3 BASIC RESEARCH
    • 7.3.1 INCREASING FUNDING BY GOVERNMENT INSTITUTES FOR BASIC RESEARCH TO DRIVE THE DEMAND FOR CELL-BASED ASSAY PRODUCTS & SERVICES
  • 7.4 OTHER APPLICATIONS

8 CELL-BASED ASSAYS MARKET, BY END USER

  • 8.1 INTRODUCTION
  • 8.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
    • 8.2.1 THE DEMAND FOR CELL-BASED ASSAYS IN THIS END-USER SEGMENT IS PRIMARILY DRIVEN BY THE GROWTH IN THE NUMBER OF R&D ACTIVITIES
  • 8.3 ACADEMIC & GOVERNMENT INSTITUTES
    • 8.3.1 INCREASING INTEREST OF ACADEMIC INSTITUTIONS TO DEVELOP ASSAYS FOR INNOVATIVE APPLICATIONS TO DRIVE THE DEMAND FOR CELL-BASED ASSAYS IN THIS END-USER SEGMENT
  • 8.4 CONTRACT RESEARCH ORGANIZATIONS
    • 8.4.1 GROWTH IN OUTSOURCING TO DRIVE THE DEMAND FOR CELL-BASED ASSAYS IN CONTRACT RESEARCH ORGANIZATIONS

9 CELL-BASED ASSAYS MARKET, BY REGION

  • 9.1 INTRODUCTION
  • 9.2 NORTH AMERICA
    • 9.2.1 US
    • 9.2.2 CANADA
  • 9.3 EUROPE
    • 9.3.1 UK
    • 9.3.2 GERMANY
    • 9.3.3 FRANCE
    • 9.3.4 REST OF EUROPE
  • 9.4 ASIA PACIFIC
    • 9.4.1 CHINA
    • 9.4.2 JAPAN
    • 9.4.3 INDIA
    • 9.4.4 REST OF ASIA PACIFIC
  • 9.5 REST OF THE WORLD

10 COMPETITIVE LANDSCAPE

  • 10.1 OVERVIEW
  • 10.2 MARKET RANKING ANALYSIS, 2017
    • 10.2.1 CELL-BASED ASSAYS MARKET RANKING, BY KEY PLAYER, 2017
  • 10.3 KEY STRATEGIES
    • 10.3.1 PRODUCT LAUNCHES, 2015-2018
    • 10.3.2 EXPANSIONS, 2015-2018
    • 10.3.3 COLLABORATIONS, 2015-2018:
    • 10.3.4 ACQUISITIONS, 2015-2018
  • 10.4 COMPETITIVE LEADERSHIP MAPPING (2017)
  • 10.5 VISIONARY LEADERS
  • 10.6 INNOVATORS
    • 10.6.1 DYNAMIC DIFFERENTIATORS
    • 10.6.2 EMERGING COMPANIES
  • 10.7 COMPETITIVE LEADERSHIP MAPPING FOR START-UPS (2017)
    • 10.7.1 PROGRESSIVE COMPANIES
    • 10.7.2 STARTING BLOCKS
    • 10.7.3 RESPONSIVE COMPANIES
    • 10.7.4 DYNAMIC COMPANIES

11 COMPANY PROFILES

(Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View)*

  • 11.1 THERMO FISHER SCIENTIFIC INC.
  • 11.2 DANAHER CORPORATION
  • 11.3 BECTON, DICKINSON AND COMPANY
  • 11.4 GE HEALTHCARE
  • 11.5 MERCK KGAA
  • 11.6 LONZA GROUP LTD.
  • 11.7 PERKINELMER, INC.
  • 11.8 CHARLES RIVER LABORATORIES, INC.
  • 11.9 CELL SIGNALING TECHNOLOGY, INC.
  • 11.10 PROMEGA CORPORATION
  • 11.11 CISBIO
  • 11.12 CELL BIOLABS, INC.

Details on Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View might not be captured in case of unlisted companies.

12 APPENDIX

  • 12.1 INSIGHTS OF INDUSTRY EXPERTS
  • 12.2 DISCUSSION GUIDE
  • 12.3 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.4 AVAILABLE CUSTOMIZATIONS
  • 12.5 RELATED REPORTS
  • 12.6 AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 2: CELL-BASED CONSUMABLES MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 3: CELL-BASED CONSUMABLES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 4: CELL-BASED REAGENTS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 5: CELL-BASED ASSAY KITS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 6: CELL-BASED ASSAY KITS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 7: REPORTER GENE ASSAYS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 8: SECOND MESSENGER ASSAYS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 9: CELL GROWTH ASSAYS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 10: CELL DEATH ASSAYS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 11: OTHER ASSAY KITS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 12: CELL-BASED PROBES & LABELS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 13: CELL-BASED MICROPLATES MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 14: CELL LINES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 15: CELL LINES MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 16: IMMORTALIZED CELL LINES MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 17: PRIMARY CELL LINES MARKET FOR, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 18: STEM CELL LINES MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 19: OTHER CONSUMABLES MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 20: CELL-BASED INSTRUMENTS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 21: CELL-BASED ASSAY SERVICES MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 22: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 23: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 24: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 25: CELL-BASED ASSAYS MARKET FOR TOXICITY STUDIES, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 26: CELL-BASED ASSAYS MARKET FOR PHARMACOKINETIC STUDIES, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 27: CELL-BASED ASSAYS MARKET FOR PHARMACODYNAMIC STUDIES, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 28: CELL-BASED ASSAYS MARKET FOR BASIC RESEARCH, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 29: CELL-BASED ASSAYS MARKET FOR OTHER APPLICATIONS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 30: CELL-BASED ASSAYS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 31: CELL-BASED ASSAYS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 32: CELL-BASED ASSAYS MARKET FOR ACADEMIC & GOVERNMENT INSTITUTES, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 33: CELL-BASED ASSAYS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 34: CELL-BASED ASSAYS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 35: NORTH AMERICA: CELL-BASED ASSAYS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 36: NORTH AMERICA: CELL-BASED ASSAYS MARKET, BY PRODUCTS & SERVICES, 2017-2024 (USD MILLION)
  • TABLE 37: NORTH AMERICA: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 38: NORTH AMERICA: CELL-BASED ASSAYS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 39: US: CELL-BASED ASSAYS MARKET, BY PRODUCTS & SERVICES, 2017-2024 (USD MILLION)
  • TABLE 40: US: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 41: US: CELL-BASED ASSAYS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 42: CANADA: CELL-BASED ASSAYS MARKET, BY PRODUCTS & SERVICES, 2017-2024 (USD MILLION)
  • TABLE 43: CANADA: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 44: CANADA: CELL-BASED ASSAYS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 45: EUROPE: CELL-BASED ASSAYS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 46: EUROPE: CELL-BASED ASSAYS MARKET, BY PRODUCTS & SERIVECS, 2017-2024 (USD MILLION)
  • TABLE 47: EUROPE: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 48: EUROPE: CELL-BASED ASSAYS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 49: UK: CELL-BASED ASSAYS MARKET, BY PRODUCTS & SERVICES, 2017-2024 (USD MILLION)
  • TABLE 50: UK: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 51: UK: CELL-BASED ASSAYS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 52: GERMANY: CELL-BASED ASSAYS MARKET, BY PRODUCTS & SERVICES, 2017-2024 (USD MILLION)
  • TABLE 53: GERMANY: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 54: GERMANY: CELL-BASED ASSAYS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 55: FRANCE: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 56: FRANCE: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 57: FRANCE: CELL-BASED ASSAYS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 58: ROE: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 59: ROE: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 60: ROE: CELL-BASED ASSAYS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 61: APAC: CELL-BASED ASSAYS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 62: APAC: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 63: APAC: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 64: APAC: CELL-BASED ASSAYS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 65: CHINA: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 66: CHINA: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 67: CHINA: CELL-BASED ASSAYS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 68: JAPAN: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 69: JAPAN: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 70: JAPAN: CELL-BASED ASSAYS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 71: INDIA: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 72: INDIA: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 73: INDIA: CELL-BASED ASSAYS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 74: ROAPAC: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 75: ROAPAC: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 76: ROAPAC: CELL-BASED ASSAYS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 77: ROW: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE, 2017-2024 (USD MILLION)
  • TABLE 78: ROW: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 79: ROW: CELL-BASED ASSAYS MARKET, BY END USER, 2017-2024 (USD MILLION)

LIST OF FIGURES

  • FIGURE 1: RESEARCH DESIGN
  • FIGURE 2: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 3: CELL-BASED ASSAYS MARKET: BOTTOM-UP APPROACH
  • FIGURE 4: CELL-BASED ASSAYS MARKET: TOP-DOWN APPROACH
  • FIGURE 5: DATA TRIANGULATION METHODOLOGY
  • FIGURE 6: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE, 2019 VS. 2024 (USD MILLION)
  • FIGURE 7: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2019 VS. 2024 (USD MILLION)
  • FIGURE 8: CELL-BASED ASSAYS MARKET, BY END USER, 2019 VS. 2024 (USD MILLION)
  • FIGURE 9: CELL-BASED ASSAYS MARKET, BY REGION, 2019 VS. 2024 (USD MILLION)
  • FIGURE 10: GROWTH IN THE NUMBER OF DRUG DISCOVERY ACTIVITIES IS DRIVING THE DEMAND FOR CELL-BASED ASSAYS
  • FIGURE 11: DRUG DISCOVERY APPLICATIONS ACCOUNTED FOR THE LARGEST SHARE OF THE CELL-BASED ASSAYS MARKET IN 2018
  • FIGURE 12: COUNTRIES IN APAC TO REGISTER A HIGHER GROWTH RATE DURING THE FORECAST PERIOD
  • FIGURE 13: CELL-BASED ASSAYS MARKET: DRIVERS, RESTRAINTS, AND OPPORTUNITIES
  • FIGURE 14: CONSUMABLES TO DOMINATE THE CELL-BASED ASSAYS MARKET DURING THE FORECAST PERIOD
  • FIGURE 15: DRUG DISCOVERY APPLICATIONS TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD
  • FIGURE 16: PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES ESTIMATED TO BE THE LARGEST END USERS OF CELL-BASED ASSAYS DURING THE FORECAST PERIOD
  • FIGURE 17: NORTH AMERICA TO DOMINATE THE CELL-BASED ASSAYS MARKET
  • FIGURE 18: NORTH AMERICA: CELL-BASED ASSAY MARKET SNAPSHOT
  • FIGURE 19: APAC: CELL-BASED ASSAYS MARKET SNAPSHOT
  • FIGURE 20: KEY DEVELOPMENTS IN THE CELL-BASED ASSAYS MARKET FROM 2015 TO 2019
  • FIGURE 21: MNM DIVE-VENDOR COMPARISON MATRIX: CELL-BASED ASSAYS MARKET
  • FIGURE 22: MNM DIVE-VENDOR COMPARISON MATRIX FOR START-UPS: CELL-BASED ASSAYS MARKET
  • FIGURE 23: THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2017)
  • FIGURE 24: DANAHER CORPORATION: COMPANY SNAPSHOT (2018)
  • FIGURE 25: BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2018)
  • FIGURE 26: GE HEALTHCARE: COMPANY SNAPSHOT (2018)
  • FIGURE 27: MERCK KGAA: COMPANY SNAPSHOT (2017)
  • FIGURE 28: LONZA GROUP LTD.: COMPANY SNAPSHOT (2017)
  • FIGURE 29: PERKINELMER, INC.: COMPANY SNAPSHOT (2018)
  • FIGURE 30: CHARLES RIVER LABORATORIES, INC.: COMPANY SNAPSHOT (2017)
Back to Top